Literature DB >> 20956

Biphasic effects of translational inhibitors on liver tyrosine aminotransferase.

F M Baccino, G Cecchini, F Palmucci, V Sverko, L Tessitore, M F Zuretti.   

Abstract

Low doses of cycloheximide or emetine cause rat liver tyrosine aminotransferase activity to rise up to twice the control levels in 2 h. By contrast, in the same interval no changes, or only a slight decrease, are produced by either drug at high dosage. Adrenalectomised animals display the same pattern of response. High doses of either antibiotic virtually afford a complete inhibition of 14C-labelled amino acid incorporation into liver and plasma proteins, whereas no more than a 30% decrease is observed with low doses. When administered in the course of the induction by cortisol, high doses of inhibitor prevent any further change in tyrosine aminotransferase activity, stabilising it at the level already attained; low doses, while slightly affecting the synthetic phase evoked by cortisol, drastically interfere with the deinduction. Six hours after various doses of either inhibitor the tyrosine aminotransferase activity is markedly increased, this late effect being largely dependent on the presence of adrenals. The amino acid incorporating actitivy of the liver may exceed that of controls, as observed particularly after small doses of emetine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20956     DOI: 10.1016/0005-2787(77)90128-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Effects of cycloheximide on protein synthesis in human lung tumors, regenerating rat liver and hepatomas.

Authors:  C Agostini; F Muci
Journal:  Experientia       Date:  1979-04-15

2.  Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide.

Authors:  F M Baccino; L Tessitore; G Cecchini; M Messina; M F Zuretti; G Bonelli; L Gabriel; J S Amenta
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.